-
Rapamycin Workflows for mTOR and Autophagy Studies
2026-09-01
Rapamycin (Sirolimus) enables controlled mTOR perturbation across oxidative-stress, cancer, immunology, and mitochondrial disease experiments. This practical guide connects dose design, autophagy readouts, and Keap1/Nrf2 validation to the findings of a mouse spermatogonial-cell study.
-
Rotigotine: From Receptor Biology to Translation
2026-08-31
Rotigotine is more than a dopamine replacement tool. Its broad receptor profile, antioxidant rationale, and dose-dependent behavioral effects create a valuable translational framework for connecting Parkinson’s disease models with motor, non-motor, and affective outcomes.
-
Dabigatran Etexilate: Oral Direct Thrombin Inhibition
2026-08-31
The reference review presents dabigatran etexilate as the first oral direct thrombin inhibitor marketed in the United States, emphasizing its rapid, predictable anticoagulant activity and CYP450-independent disposition. Its practical significance lies in reducing reliance on INR-based dose adjustment while highlighting renal function, bleeding, and gastrointestinal tolerability as essential considerations.
-
Rotigotine hydrochloride: Research Workflows
2026-08-30
Rotigotine hydrochloride supports integrated cell, behavioral, and Parkinson’s disease model workflows through sustained dopaminergic stimulation. This guide translates published depression-model findings into practical dose selection, assay controls, formulation steps, and troubleshooting strategies.
-
SERCA2–CaN/FoxO1/FABP4 Axis in Atherosclerosis
2026-08-29
The 2025 British Journal of Pharmacology study identifies the calcineurin/FoxO1/FABP4 pathway as a mechanistic link between SERCA2 dysfunction, altered fatty acid handling, macrophage foam cell formation, and atherosclerosis. Its combination of a SERCA2 C674S knock-in model, metabolomics, macrophage assays, pharmacological inhibition, and partial FABP4 deficiency provides a framework for testing FABP4-directed interventions in vascular disease.
-
Phosbind Acrylamide for Plant Kinase Assays
2026-08-28
Phosbind Acrylamide enables antibody-independent protein phosphorylation analysis by converting phosphate-dependent interactions into SDS-PAGE mobility shifts. This article applies the method to the SlIDL6–Ca2+–SlCPK10 pathway in tomato and explains how to design, control, and interpret phosphorylation assays.
-
Gap19: Precision in Cx43 Translational Research
2026-08-28
A mechanistic and strategic guide to using Gap19 as a selective Cx43 hemichannel blocker in neuroprotection, astrocyte ATP-release assays, macrophage inflammation, and ischemia/reperfusion research.
-
Ionomycin free acid: A FAK Stress-Test
2026-08-27
Ionomycin free acid provides a controlled calcium perturbation for examining how intracellular calcium increase may intersect with FAISL, Calpain 2, and FAK stability in triple-negative breast cancer models. This article translates the reference study into a decision framework for distinguishing calcium-dependent proteolysis from changes in FAK expression or adhesion signaling.
-
Biotin Azide: From Click Labeling to Translational Insight
2026-08-27
A mechanism-first guide to using Biotin Azide for labeling alkynylated biomolecules, affinity capture, and translational investigation of the Fzd5–cholesterol–Wnt/β-catenin axis in pancreatic cancer. The article connects CuAAC chemistry with experimental strategy, assay controls, reagent selection, and the limitations that matter when moving from molecular labeling to disease-relevant conclusions.
-
(S)-(+)-Methoprene in Insect Hormone Assays
2026-08-26
Use (S)-(+)-Methoprene as a controlled juvenile hormone analog to connect Methoprene-tolerant receptor signaling with developmental, reproductive, and endocrine-disruption phenotypes. This practical guide outlines assay design, dose and solvent handling, miRNA-informed experiments, and troubleshooting strategies for arthropod research.
-
CSBTA Pharmacokinetics in MASH: Integrated Evidence
2026-08-26
The reference study integrates plasma pharmacokinetics, tissue distribution, cellular accumulation, and enzyme/transporter assays to explain how MASH alters exposure to Corydalis saxicola Bunting total alkaloids. Its findings support disease-state-aware dosing and highlight PXR-associated regulation of CYP450s, Oatp1b2, and P-gp as important sources of pharmacokinetic variability.
-
Cabazitaxel (XRP6258) Protocol for Resistant Models
2026-08-25
Cabazitaxel (XRP6258) is a semi-synthetic taxane derivative for investigating microtubule dynamics disruption in taxane-resistant and P-glycoprotein-expressing cancer cell models. It is suitable for DMSO- or ethanol-based workflows, but not aqueous preparation, and prepared solutions should be used promptly rather than stored long term.
-
Phosbind Acrylamide for Phosphorylation Analysis
2026-08-25
Phosbind Acrylamide turns a standard SDS-PAGE workflow into an antibody-independent assay for phosphorylation-dependent mobility shifts. This guide shows how to apply it to ABA signaling research, choose appropriate controls, and troubleshoot gel conditions without overinterpreting a band shift as site-specific proof.
-
Liproxstatin-1: Ferroptosis Inhibitor Guide
2026-08-24
Liproxstatin-1 is a small-molecule ferroptosis inhibitor that suppresses iron-dependent lipid peroxidation. Product data report an IC50 of 22 nM in an RSL3-induced cell-death assay and protection in GPX4-deficient and renal injury models.
-
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody Workflow
2026-08-24
Build reproducible immunofluorescence, ICC, IHC, and flow cytometry workflows around a Cy3-conjugated secondary antibody for rabbit primary antibodies. This guide translates ulcerative-colitis biology into practical staining, control, imaging, and troubleshooting decisions without implying that the reference study validated this reagent directly.